EPS

(redirected from Extrapyramidal syndrome)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Extrapyramidal syndrome: tardive dyskinesia, neuroleptic malignant syndrome, dystonia

EPS

Earnings per Share

In a given fiscal year, a publicly-traded company's profit divided by the number of shares outstanding. This is considered the single most important aspect in determining a share's price and value, because the calculation of earnings per share shows the amount of money to which a shareholder would be entitled in the event of the company's liquidation. In general, earnings per share applies only to common shares. It is calculated thusly:

Earnings per share = (Net income - Preferred dividends) / Average shares outstanding.

EPS

Earnings per share (EPS).

Earnings per share (EPS) is calculated by dividing a company's total earnings by the number of outstanding shares.

For example, if a company earns $100 million in a year and has 50 million outstanding shares, the earnings per share are $2.

Earnings per share can also be calculated on a fully diluted basis, by adding outstanding stock options, rights, and warrants to the outstanding shares.

The results report what EPS would be if all of those options, rights, and warrants were exercised and the company had to issue more shares to meet its obligations.

Earnings and other financial measures are provided on a per share basis to make it easier for you to analyze the information and compare the results to those of other investments.

References in periodicals archive ?
In short-term (4- and 6-week) placebo-controlled trials, there was no statistical difference in the incidence of discontinuation due to adverse events between patients treated with aripiprazole and placebo (7% and 9%, respectively) or incidence of extrapyramidal syndrome (6% vs.
In short-term (4- and 6-week) placebo-controlled trials, there was no difference in the incidence of discontinuation due to adverse events between patients treated with ABILIFY (7%) and placebo (9%) or incidence of extrapyramidal syndrome (6% vs.
The most frequent side effects reported by patients in advanced stages of PD who were treated with pramipexole and levodopa were postural hypotension, dyskinesias, extrapyramidal syndrome, insomnia, dizziness and hallucinations.

Full browser ?